Essex LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,430
Closed -$967K 175
2024
Q2
$967K Sell
10,430
-435
-4% -$39K 0.22% 79
2024
Q1
$1.03M Sell
10,865
-1,122
-9% -$104K 0.24% 77
2023
Q4
$1.07M Sell
11,987
-7,122
-37% -$529K 0.27% 77
2023
Q3
$1.4M Sell
19,109
-7,318
-28% -$585K 0.39% 64
2023
Q2
$2.2M Sell
26,427
-3,887
-13% -$325K 0.61% 47
2023
Q1
$2.52M Hold
30,314
0.76% 43
2022
Q4
$2.52M Sell
30,314
-5
-0% -$405 0.76% 43
2022
Q3
$2.4M Buy
30,319
+5,541
+22% +$467K 0.79% 44
2022
Q2
$1.84M Sell
24,778
-822
-3% -$61.7K 0.57% 58
2022
Q1
$2.3M Buy
25,600
+2,026
+9% +$187K 0.62% 52
2021
Q4
$2.64M Buy
23,574
+1,970
+9% +$238K 0.71% 46
2021
Q3
$2.72M Buy
+21,604
New +$2.78M 0.75% 45

Other funds holding XBI